NetCents Technology Inc.: NetCents Technology Announces Passing of Founder Clayton Moore and Appointment of New President | Vancouver, British Columbia--(Newsfile Corp. - February 6, 2025) - NetCents Technology Inc. (CSE: NC) ("NetCents" or the "Company") announces the unexpected passing of its founder, Clayton Moore, and... ► Artikel lesen |
Clinuvel Pharmaceuticals Limited: CLINUVEL recruits 200 patients in Phase III vitiligo trial CUV105 | Executive summary Recruitment target of 200 vitiligo patients (Fitzpatrick skin type III-VI) in CUV105 study achievedRandomised trial, 20-week treatment protocol plus 6-month follow upStudy sites... ► Artikel lesen |
EQS-Media: CLINUVEL: Rekordhalbjahr bestätigt Erfolgskurs - PARMANTIER & CIE. präsentiert aktuelle Research-Studie zu den Halbjahreszahlen von CLINUVEL Pharmaceuticals | EQS-Media / 07.03.2025 / 16:27 CET/CEST
Frankfurt am Main, 07. März 2025 - CLINUVEL Pharmaceuticals Ltd. (ASX: CUV - ADR Level1: CLVLY - Börse Frankfurt/M: UR9 - ISIN: AU000000CUV3) setzt seinen... ► Artikel lesen |
Original-Research: CLINUVEL Pharmaceuticals (von Parmantier & Cie. GmbH): BUY | Original-Research: CLINUVEL Pharmaceuticals - from Parmantier & Cie. GmbH 07.03.2025 / 16:21 CET/CEST Dissemination of a Research, transmitted by EQS News - a service of EQS Group. The issuer is... ► Artikel lesen |
Auxly Cannabis Group Inc.: Auxly Reports 2024 Fourth Quarter and Full Year Results: Achieves Record Sales and Profitability, Back Forty exits 2024 as the #1 Brand in Canada | TORONTO, March 20, 2025 /PRNewswire/ - Auxly Cannabis Group Inc. (TSX: XLY) (OTCQB: CBWTF) ("Auxly" or the "Company") a leading consumer packaged goods company... ► Artikel lesen |